BridgeBio Pharma, Inc. (MUN:2CL)
Germany · Delayed Price · Currency is EUR 62.18
+7.98 (14.72%)
At close: Dec 1, 2025
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of €12.21 billion as of December 15, 2025. Its market cap has increased by 148.16% in one year.
Market Cap
12.21B
Enterprise Value
13.25B
Revenue
301.53M
Ranking
n/a
PE Ratio
n/a
Stock Price
€62.18
Market Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from 2.92B to 12.21B, an increase of 318.02%. That is a compound annual growth rate of 24.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 12.21B | 143.74% |
| Dec 31, 2024 | 5.01B | -21.16% |
| Dec 29, 2023 | 6.35B | 496.14% |
| Dec 30, 2022 | 1.07B | -50.63% |
| Dec 31, 2021 | 2.16B | -69.70% |
| Dec 31, 2020 | 7.13B | 84.61% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 244.16B |
| Siemens Aktiengesellschaft | 186.18B |
| Allianz SE | 145.75B |
| Deutsche Telekom AG | 126.33B |
| Siemens Energy AG | 101.53B |
| Rheinmetall AG | 72.19B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 71.18B |
| Deutsche Bank Aktiengesellschaft | 61.07B |